| Prev Close: | 110.37 |
|---|---|
| Open: | N/A |
| Bid: | 106.92 x 100 |
| Ask: | 113.61 x 100 |
| NAV¹: | 59.82 |
| Net Assets²: | 758.66M |
| YTD Return (Mkt)²: | 13.67% |
| Day's Range: | N/A - N/A |
|---|---|
| 52wk Range: | 77.00 - 112.69 |
| Volume: | 0 |
| Avg Vol (3m): | 232,008 |
| P/E (ttm)²: | 28 |
| Yield (ttm)²: |
¹As of Nov 29, 2012
²As of Mar 30, 2013
Headlines
- Biotech ETF Rallies Over 30% as Cash Tumbles InETF Trends(Wed, May 22)
- Biotechnology ETF Investing 101Zacks(Mon, May 20)
- Positive Prognosis for Biotech ETFsETF Trends(Fri, May 10)
- Double-Digit Returns from the Biotechnology Strategyat Motley Fool(Wed, May 8)
- XBI, NPSP, THRX, BIIB: Large Outflows Detected at ETFat Forbes(Tue, May 7)
- Investors Clamor for Generic Drug ETFETF Trends(Mon, May 6)
- I Would Buy a Generic Drug ETF, If One Existedat Motley Fool(Thu, May 2)
- Is the Biotech Sector Still a Market Leader?Zacks(Wed, Apr 24)
- Beat Obamacare With These Biotech ETFsat Seeking Alpha(Mon, Apr 22)
- 3 Sector ETFs Surviving This SlumpZacks(Thu, Apr 18)
- 3 Sector ETFs Surviving This SlumpZacks(Thu, Apr 18)
- Final Trade: Your First Move for Wednesday, April 17at CNBC(Tue, Apr 16)
- [video] FMHR Final Tradeat CNBC(Tue, Apr 16)
- Playing To The Strengths Of Biotechat Seeking Alpha(Sat, Apr 13)
- Under The Hood: An Unheralded Biotech ETFat Seeking Alpha(Thu, Apr 11)
Reports
- XBI: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(May 24)
- Trading Report for (XBI). A detailed report, including free correlated market...Stock Traders Daily(May 23)
- The Investment Rate - a measure of investment demand.Stock Traders Daily(May 21)
